Neurocentriaincis A Late Stage Biotechnology Company Focused On Developing Innovative Treatments For Neurodegenerative And Neuropsychiatric Disordersthe Company Aims To Create Life Changing Therapies That Enhance Synaptic Function And Promote Synaptogenesisproviding New Hope For Patients Affected By These Conditions Neurocentria Is Currently Developing Several Drugsincluding Nrct 101 Sr For Depressive Disordersnrct 202Xr For Alzheimer S Diseaseand Nrct 201Xr For Attention Deficit Hyperactivity Disorderadhd All In Various Stages Of Clinical Trialsadditionallythe Company Offers A Nutraceutical Designed To Improve Brain Health In Healthy Individualsthe Leadership Teamled By Drliuincludes Experts With Extensive Experience In Neuroscience And Drug Developmentneurocentria Promotes A Collaborative Work Environment And Values Employee Contributionsoffering A Range Of Benefits To Its Staffthe Company Is Headquartered In Walnut Creekcalifornia
No conferences found for this company.
| Company Name | Neurocentria Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
